Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Polymorphism (Genetics). Found 14 abstracts

Le Marchand L, Guo C, Benhamou S, Bouchardy C, Cascorbi I, Clapper ML, Garte S, Haugen A, Ingelman-Sundberg M, Kihara M, Rannug A, Ryberg D, Stucker I, Sugimura H, Taioli E. Pooled analysis of the CYP1A1 exon 7 polymorphism and lung cancer (United States). Cancer causes & control : CCC. 2003 May;14(4):339-46.
Townsend D, Tew K. Cancer drugs, genetic variation and the glutathione-S-transferase gene family. Am J Pharmacogenomics. 2003 Jan;3(3):157-72.
Calvert PM, Frucht H. The genetics of colorectal cancer. Annals of internal medicine. 2002 Oct;137(7):603-12.
Russo J, Lareef MH, Tahin Q, Hu YF, Slater C, Ao X, Russo IH. 17Beta-estradiol is carcinogenic in human breast epithelial cells. J Steroid Biochem Mol Biol. 2002 Feb;80(2):149-62.
Carlini EJ, Raftogianis RB, Wood TC, Jin F, Zheng W, Rebbeck TR, Weinshilboum RM. Sulfation pharmacogenetics: SULT1A1 and SULT1A2 allele frequencies in Caucasian, Chinese and African-American subjects. Pharmacogenetics. 2001 Feb;11(1):57-68.
De Rienzo A, Balsara BR, Apostolou S, Jhanwar SC, Testa JR. Loss of heterozygosity analysis defines a 3-cM region of 15q commonly deleted in human malignant mesothelioma. Oncogene. 2001 Sep 27;20(43):6245-9.
Garte S, Gaspari L, Alexandrie AK, Ambrosone C, Autrup H, Autrup JL, Baranova H, Bathum L, Benhamou S, Boffetta P, Bouchardy C, Breskvar K, Brockmoller J, Cascorbi I, Clapper ML, Coutelle C, Daly A, Dell'Omo M, Dolzan V, Dresler CM, Fryer A, Haugen A, Hein DW, Hildesheim A, Hirvonen A, Hsieh LL, Ingelman-Sundberg M, Kalina I, Kang D, Kihara M, Kiyohara C, Kremers P, Lazarus P, Le Marchand L, Lechner MC, van Lieshout EM, London S, Manni JJ, Maugard CM, Morita S, Nazar-Stewart V, Noda K, Oda Y, Parl FF, Pastorelli R, Persson I, Peters WH, Rannug A, Rebbeck T, Risch A, Roelandt L, Romkes M, Ryberg D, Salagovic J, Schoket B, Seidegard J, Shields PG, Sim E, Sinnet D, Strange RC, Stucker I, Sugimura H, To-Figueras J, Vineis P, Yu MC, Taioli E. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev. 2001 Dec;10(12):1239-48.
Wang WW, Spurdle AB, Kolachana P, Bove B, Modan B, Ebbers SM, Suthers G, Tucker MA, Kaufman DJ, Doody MM, Tarone RE, Daly M, Levavi H, Pierce H, Chetrit A, Yechezkel GH, Chenevix-Trench G, Offit K, Godwin AK, Struewing JP. A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers. Cancer Epidemiol Biomarkers Prev. 2001 Sep;10(9):955-60.
Astrinidis A, Khare L, Carsillo T, Smolarek T, Au KS, Northrup H, Henske EP. Mutational analysis of the tuberous sclerosis gene TSC2 in patients with pulmonary lymphangioleiomyomatosis. J Med Genet. 2000 Jan;37(1):55-7.
Clapper ML. Genetic polymorphism and cancer risk. Current oncology reports. 2000 May;2(3):251-6.
Dresler CM, Fratelli C, Babb J, Everley L, Evans AA, Clapper ML. Gender differences in genetic susceptibility for lung cancer. Lung Cancer. 2000 Dec;30(3):153-60.
Kruger WD, Evans AA, Wang L, Malinow MR, Duell PB, Anderson PH, Block PC, Hess DL, Graf EE, Upson B. Polymorphisms in the CBS gene associated with decreased risk of coronary artery disease and increased responsiveness to total homocysteine lowering by folic acid. Molecular genetics and metabolism. 2000 May;70(1):53-60.
Kulinski J, Besack D, Oleykowski CA, Godwin AK, Yeung AT. CEL I enzymatic mutation detection assay. Biotechniques. 2000 Jul;29(1):44-6, 48.
Raftogianis R, Creveling C, Weinshilboum R, Weisz J. Estrogen metabolism by conjugation. J Natl Cancer Inst Monogr. 2000 Jan;(27):113-24.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Polymorphism (Genetics)

Polymorphism (Genetics) genetics Human US Gov't Support-PHS Non-US Gov't Support Female Male Middle Age metabolism Risk Factors Genetic Predisposition to Disease Aged Glutathione Transferase Adult Breast Neoplasms physiology Sex Factors Lung Neoplasms Case-Control Studies toxicity 80 and over Aged therapeutic use Smoking Negroid Race Sulfotransferases Loss of Heterozygosity Gene Frequency Neoplasms Microsatellite Repeats US Gov't Support-Non-PHS Cultured Tumor Cells Exons United States Caucasoid Race Alleles Tumor Suppressor Genes Cytochrome P-450 CYP1A1 epidemiology Genotype Genetic Screening Amino Acid Substitution cytology drug effects Estradiol analysis Amine Oxidoreductases Analysis of Variance Cytochrome P-450 Enzyme System Transformed Cell Line Isoenzymes Catechol O-Methyltransferase methods Adenomatous Polyposis Coli Neoplasm Proteins Repressor Proteins Risk Assessment Adenocarcinoma Factual Databases Sensitivity and Specificity Cystathionine beta-Synthase Jews Comparative Study Environmental Carcinogens adverse effects Racial Stocks Pedigree Haplotypes Estrogens chemically Transcription Factors Catechol Estrogens Human Chromosomes-Pair 15 Software Adolescent Colorectal Neoplasms Age Factors Breast Israel Neoplastic Cell Transformation blood DNA Mutational Analysis Genetic Counseling Antineoplastic Agents induced Ovarian Neoplasms Glucuronosyltransferase Homocysteine Odds Ratio Chromosome Deletion BRCA1 Protein Chemical Models DNA Lymphangiomyomatosis pharmacology Mesothelioma Epithelial Cells Polymerase Chain Reaction Mongoloid Race Australia Coronary Disease Variation (Genetics) Fluorescence In Situ Hybridization BRCA1 Genes Polyacrylamide Gel Electrophoresis Folic Acid Chromosome Mapping Mutation Hereditary Nonpolyposis Colorectal Neoplasms pathology Heterozygote Genetic Models enzymology BRCA2 Protein drug therapy Logistic Models Linkage (Genetics) Diethylstilbestrol Endonucleases Missense Mutation Tuberous Sclerosis Oncogenes Artificial Chromosomes-Yeast Squamous Cell Carcinoma Enzyme Stability Base Sequence Linkage Disequilibrium DNA-Binding Proteins Carcinogens etiology 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase Treatment Outcome
Last updated on Wednesday, February 05, 2020